Pacira Pharmaceuticals, Inc., a Delaware corporation, is the holding company for
our California operating subsidiary of the same name, or Pacira California. In
March 2007, we acquired Pacira California from SkyePharma Holdings, Inc., or
Skyepharma (referred to in this Annual Report on Form 10-K as the
"Acquisition"). Unless the context requires otherwise, references to "Pacira,"
"we," the "Company," "us" and "our" in this Annual Report on Form 10-K refers to
Pacira Pharmaceuticals, Inc., a Delaware corporation, and its subsidiaries.
We were incorporated in Delaware under the name Blue Acquisition Corp. in
December 2006 and changed our name to Pacira, Inc. in June 2007. In October
2010, we changed our name to Pacira Pharmaceuticals, Inc. Our principal
executive offices are located in Parsippany, New Jersey.